Pictet North America Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$883K Hold
6,875
0.08% 106
2026
Q1
$827K Hold
6,875
0.08% 101
2025
Q4
$724K Hold
6,875
0.07% 104
2025
Q3
$577K Hold
6,875
0.05% 106
2025
Q2
$544K Hold
6,875
0.05% 107
2025
Q1
$617K Sell
6,875
-654
-9% -$61.1K 0.06% 100
2024
Q4
$749K Hold
7,529
0.07% 104
2024
Q3
$855K Buy
7,529
+154
+2% +$18.3K 0.08% 98
2024
Q2
$913K Hold
7,375
0.1% 97
2024
Q1
$973K Hold
7,375
0.11% 95
2023
Q4
$804K Hold
7,375
0.1% 89
2023
Q3
$759K Sell
7,375
-300
-4% -$32.3K 0.11% 92
2023
Q2
$886K Hold
7,675
0.12% 85
2023
Q1
$817K Hold
7,675
0.13% 82
2022
Q4
$852K Hold
7,675
0.15% 76
2022
Q3
$661K Buy
7,675
+300
+4% +$26.8K 0.11% 89
2022
Q2
$672K Hold
7,375
0.09% 95
2022
Q1
$605K Sell
7,375
-652
-8% -$51.4K 0.07% 96
2021
Q4
$615K Hold
8,027
0.06% 94
2021
Q3
$603K Hold
8,027
0.06% 94
2021
Q2
$624K Buy
8,027
+139
+2% +$10.3K 0.06% 94
2021
Q1
$580K Hold
7,888
0.07% 93
2020
Q4
$616K Buy
7,888
+160
+2% +$12.2K 0.08% 96
2020
Q3
$612K Buy
7,728
+313
+4% +$24.5K 0.09% 91
2020
Q2
$547K Hold
7,415
0.08% 98
2020
Q1
$544K Sell
7,415
-511
-6% -$40.2K 0.09% 100
2019
Q4
$688K Sell
7,926
-327
-4% -$26.9K 0.08% 101
2019
Q3
$663K Hold
8,253
0.09% 100
2019
Q2
$660K Sell
8,253
-2,747
-25% -$210K 0.1% 99
2019
Q1
$873K Buy
11,000
+43
+0.4% +$3.22K 0.13% 88
2018
Q4
$799K Hold
10,957
0.07% 96
2018
Q3
$742K Buy
+10,957
New +$698K 0.1% 100
2018
Q1
Sell
-39,552
Closed -$2.12M 140
2017
Q4
$2.12M Buy
39,552
+8,788
+29% +$487K 0.33% 51
2017
Q3
$1.88M Sell
30,764
-2,253
-7% -$137K 0.3% 58
2017
Q2
$2.02M Sell
33,017
-1,127
-3% -$68.6K 0.34% 53
2017
Q1
$2.07M Buy
34,144
+2,856
+9% +$173K 0.35% 51
2016
Q4
$1.76M Sell
31,288
-11,566
-27% -$677K 0.39% 52
2016
Q3
$2.55M Buy
42,854
+566
+1% +$33.1K 0.61% 27
2016
Q2
$2.33M Sell
42,288
-297
-0.7% -$15.8K 0.54% 30
2016
Q1
$2.15M Buy
42,585
+9,117
+27% +$447K 0.45% 31
2015
Q4
$1.69M Buy
33,468
+5,045
+18% +$254K 0.39% 29
2015
Q3
$1.34M Buy
+28,423
New +$1.51M 0.37% 24
2015
Q2
Sell
-31,420
Closed -$1.72M 72
2015
Q1
$1.72M Sell
31,420
-419
-1% -$23.7K 0.33% 26
2014
Q4
$1.73M Buy
31,839
+23,134
+266% +$1.29M 0.35% 27
2014
Q3
$492K Buy
8,705
+1,468
+20% +$82.4K 0.12% 35
2014
Q2
$400K Sell
7,237
-8,149
-53% -$445K 0.1% 27
2014
Q1
$833K Buy
15,386
+4,612
+43% +$239K 0.23% 29
2013
Q4
$515K Buy
+10,774
New +$492K 0.12% 40

Other funds holding MRK

Pictet North America Advisors's MRK Position: Q2 2026 in Review

Pictet North America Advisors held its Merck (MRK) position steady in Q2 2026 at 6,875 shares worth $883K. The position accounts for 0.08% of the portfolio, ranked #106.

Pictet North America Advisors first reported a position in MRK in Q4 2013 and has held it in 48 quarters since. The position peaked at $2.55M in Q3 2016. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Pictet North America Advisors held 6,875 shares of Merck worth $883K as of Q2 2026.
  • Pictet North America Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.08% of Pictet North America Advisors's portfolio in Q2 2026, its #106 holding.
  • Pictet North America Advisors first reported a position in Merck in Q4 2013 and has held it in 48 quarters since.
  • Pictet North America Advisors's Merck position peaked at $2.55M in Q3 2016.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Pictet North America Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.